Riggs CW - Search Results

1

Enhancement of vincristine cytotoxicity in drug-resistant cells by simultaneous treatment with onconase, an antitumor ribonuclease.

Rybak SM, Pearson JW, Fogler WE, Volker K, Spence SE, Newton DL, Mikulski SM, Ardelt W, Riggs CW, Kung HF, Longo DL. Rybak SM, et al. Among authors: riggs cw. J Natl Cancer Inst. 1996 Jun 5;88(11):747-53. doi: 10.1093/jnci/88.11.747. J Natl Cancer Inst. 1996. PMID: 8637029

2

Reversal of drug resistance in a human colon cancer xenograft expressing MDR1 complementary DNA by in vivo administration of MRK-16 monoclonal antibody.

Pearson JW, Fogler WE, Volker K, Usui N, Goldenberg SK, Gruys E, Riggs CW, Komschlies K, Wiltrout RH, Tsuruo T, et al. Pearson JW, et al. Among authors: riggs cw. J Natl Cancer Inst. 1991 Oct 2;83(19):1386-91. doi: 10.1093/jnci/83.19.1386. J Natl Cancer Inst. 1991. PMID: 1681110

3

Enhancement by recombinant human interferon alfa of the reversal of multidrug resistance by MRK-16 monoclonal antibody.

Fogler WE, Pearson JW, Volker K, Ariyoshi K, Watabe H, Riggs CW, Wiltrout RH, Longo DL. Fogler WE, et al. Among authors: riggs cw. J Natl Cancer Inst. 1995 Jan 18;87(2):94-104. doi: 10.1093/jnci/87.2.94. J Natl Cancer Inst. 1995. PMID: 7707396

4

Restoration of interferon alpha potentiation of a recombinant ricin A chain immunotoxin following cytoreduction of xenografts of advanced ovarian tumors.

Pearson JW, Fogler WE, Volker K, Riggs CW, Gruys E, Groves ES, Wiltrout RH, Longo DL. Pearson JW, et al. Among authors: riggs cw. J Natl Cancer Inst. 1993 Jun 2;85(11):907-12. doi: 10.1093/jnci/85.11.907. J Natl Cancer Inst. 1993. PMID: 8492319

5

Enhanced therapeutic efficacy against an ovarian tumor xenograft of immunotoxins used in conjunction with recombinant alpha-interferon.

Pearson JW, Hedrick E, Fogler WE, Bull RL, Ferris DK, Riggs CW, Wiltrout RH, Sivam G, Morgan AC, Groves E, et al. Pearson JW, et al. Among authors: riggs cw. Cancer Res. 1990 Oct 1;50(19):6379-88. Cancer Res. 1990. PMID: 2144790

6

Transplacental effects of 3'-azido-2',3'-dideoxythymidine (AZT): tumorigenicity in mice and genotoxicity in mice and monkeys.

Olivero OA, Anderson LM, Diwan BA, Haines DC, Harbaugh SW, Moskal TJ, Jones AB, Rice JM, Riggs CW, Logsdon D, Yuspa SH, Poirier MC. Olivero OA, et al. Among authors: riggs cw. J Natl Cancer Inst. 1997 Nov 5;89(21):1602-8. doi: 10.1093/jnci/89.21.1602. J Natl Cancer Inst. 1997. PMID: 9362158

7

DNA adducts of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) in colon, bladder, and kidney of congenic mice differing in Ah responsiveness and N-acetyltransferase genotype.

Nerurkar PV, Schut HA, Anderson LM, Riggs CW, Snyderwine EG, Thorgeirsson SS, Weber WW, Rice JM, Levy GN. Nerurkar PV, et al. Among authors: riggs cw. Cancer Res. 1995 Jul 15;55(14):3043-9. Cancer Res. 1995. PMID: 7606725

8

N-nitrosocimetidine as a modifier of chemically-initiated tumors in mice.

Anderson LM, Hagiwara A, Giner-Sorolla A, Kovatch RM, Rehm S, Riggs CW, Rice JM. Anderson LM, et al. Among authors: riggs cw. Cancer Lett. 1988 Nov;42(3):159-67. doi: 10.1016/0304-3835(88)90300-x. Cancer Lett. 1988. PMID: 3142678

9

Dose-response study with N-nitrosomorpholine in drinking water of F-344 rats.

Lijinsky W, Kovatch RM, Riggs CW, Walters PT. Lijinsky W, et al. Among authors: riggs cw. Cancer Res. 1988 Apr 15;48(8):2089-95. Cancer Res. 1988. PMID: 3349480

10

Inhibition of vascular endothelial growth factor-induced endothelial cell migration by ETS1 antisense oligonucleotides.

Chen Z, Fisher RJ, Riggs CW, Rhim JS, Lautenberger JA. Chen Z, et al. Among authors: riggs cw. Cancer Res. 1997 May 15;57(10):2013-9. Cancer Res. 1997. PMID: 9157999

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64 results

Search Page

Filters